Clinical Trials Browser

Phase 2 × Resveratrol × Plasma cell × Clear all

NCT00920556 2019-02-27

A Clinical Study to Assess the Safety and Activity of SRT501 Alone or in Combination With Bortezomib in Patients With Multiple Myeloma

Phase 2 Terminated

24 enrolled 24 charts

Multiple Myeloma